Precision Health AI (PH.AI) is developing the leading artificial intelligence (AI) platform for oncology built on deep clinical oncology data to enable the practice of precision medicine for better cancer patient care and to accelerate cancer-related drug development, trials, and real world evidence for the benefit of patients, oncologists, and the cancer care ecosystem. To learn more, visit www.precisionhealth.ai
As a healthcare technology company, PH.AI’s AI platform is trained specifically for oncology, leverages proprietary and unique data sources, and integrates seamlessly into the existing workflows of healthcare manufacturers, providers, and payers, with the goal of improving oncology outcomes. With the aid of its industry-leading AI platform, PH.AI analyzes large sets of cancer patient data from a variety of settings including observational studies, clinical trials, and real world evidence such as genomic sequencing data, EMR/EHR, and claims, to identify which treatments work for which cancer patients, why, in what context, and at what cost, with the goal of developing tailored treatment regimens for each patient. PHAI is unlocking the promise of precision medicine, one cancer patient at a time.
Send us an email